Location: Melbourne
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Melbourne
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease NA · The Alfred Hospital · Efemoral Medical, Inc. · NCT04584632 HEAT Trial (HER2 Antibody Therapy With Lutetium-177) EARLY_Phase 1 · Radiopharm Theranostics, Ltd · NCT06824155 Observational Study Protocol: LIVER-R Phase N/A · Research Site · AstraZeneca · NCT06252753 Precision Medicine for Every Child With Cancer Phase N/A · Monash Children's Hospital · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772 A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants Phase 1 · Nucleus Network Ply Ltd. · Jiangsu Carephar Pharmaceutical Co., Ltd. · NCT06627556 The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias Phase 1/Phase 2 · The Alfred Hospital · Lin BioScience, Inc · NCT05756322 A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants Phase 1 · Nucleus Network · Septerna, Inc. · NCT07433179 AusCADASIL: An Australian Cohort of CADASIL Phase N/A · Royal Melbourne Hospital · Perminder Sachdev · NCT06148051 Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain NA · Saluda Medical Pty Ltd · NCT04662905 Performance After Cardiac Ablation in Endurance Athletes for Atrial Fibrillation NA · St. Vincent's Hospital · University Hospital of Leuven Leuven · NCT07726056 Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial NA · GenesisCare Ringwood · Palette Life Sciences, Inc. · NCT06496256 A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurr Phase 2 · Peter MacCallum Cancer Centre · Yonsei University · NCT06023862 Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study NA · The Alfred Hospital · University of Melbourne · NCT07055542 Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy Phase 1 · Consano Bio Research Site · Consano Bio · NCT07264270 An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07665437 A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili Phase 1/Phase 2 · Peter MacCallum Cancer Centre · Lumara Bio Oncologics GmbH · NCT05706129 Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) Phase 1 · Peter MacCallum Cancer Center · Ichnos Sciences SA · NCT05862012 First-Time-in-Human Study of GSK5471713 in Adults With mCRPC Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT07332455 A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Ho Phase 1 · Peter MacCallum Cancer Centre · Murdoch Childrens Research Institute · NCT06383338 A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe Phase 2 · Relay Therapeutics, Inc. · NCT06789913 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag Phase 3 · Travere Therapeutics, Inc. · NCT06247085 Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis Phase 1 · Paratus Clinical Research Melbourne · TRex Bio, Inc. · NCT06934252 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop Phase 3 · Peter Maccallum Cancer Centre · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au Phase 3 · Local Institution - 0108 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit Phase 1/Phase 2 · Bristol-Myers Squibb · NCT07291076 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · The Alfred Hospital · Amgen · NCT07037433 A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC Phase 1 · The Alfred Hospital · Myeloid Therapeutics · NCT06478693 A Novel Drug for Borderline Personality Disorder Phase 2 · Monash Alfred Psychiatry Research Centre · The Alfred · NCT02097706 Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag Phase 1 · The Alfred Hospital /ID# 265981 · AbbVie · NCT06896916 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034
Look up another city
Look up another condition
EICHOR